首页> 外文期刊>Cardiovascular Research >Control of cardiac excitability by microRNAs.
【24h】

Control of cardiac excitability by microRNAs.

机译:通过microRNA控制心脏兴奋性。

获取原文
获取原文并翻译 | 示例
           

摘要

Cardiovascular disease is the leading cause of morbidity and mortality in developed countries. The pathological process of the heart is associated with an altered expression profile of genes that are important for cardiac function. MicroRNAs (miRNAs) have recently emerged as one of the central players of gene expression regulation. The implications of miRNAs in the pathological process of the cardiovascular system have recently been recognized, and research on miRNAs in relation to cardiovascular disease has now become a most rapidly evolving field. In this review, we focus on miRNAs and control of cardiac excitability, aiming to provide a comprehensive overview on the available experimental data on regulation of cardiac conduction, repolarization, and automaticity by miRNAs. Aberrant expression of miRNAs in the diseased state of the heart and their arrhythmogenic or anti-arrhythmic potential will be discussed. Finally, the innovative miRNA-interference technologies developed lately for manipulating the action of miRNAs by interfering with their expression, stability, and function as new approaches for miRNA research and gene therapy will be introduced.
机译:在发达国家,心血管疾病是发病率和死亡率的主要原因。心脏的病理过程与对心脏功能重要的基因的表达变化有关。 MicroRNA(miRNA)最近已成为基因表达调控的主要参与者之一。最近已经认识到miRNA在心血管系统病理过程中的意义,并且与心血管疾病有关的miRNA研究现已成为发展最快的领域。在这篇综述中,我们专注于miRNA和心脏兴奋性的控制,旨在提供有关miRNA调节心脏传导,复极化和自动性的可用实验数据的全面概述。将讨论心脏疾病状态下miRNA的异常表达及其心律失常或抗心律失常的潜力。最后,将介绍最近开发的通过干扰miRNA的表达,稳定性和功能来操纵miRNA的作用的创新miRNA干扰技术,以此作为miRNA研究和基因治疗的新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号